• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Associations between public health measures and mortality among hospitalised COVID-19 patients: a cross-sectional study in Malaysia

tetano

Editor, Senior Moderator
Sci Rep


. 2025 Jul 1;15(1):21141.
doi: 10.1038/s41598-025-07363-1. Associations between public health measures and mortality among hospitalised COVID-19 patients: a cross-sectional study in Malaysia

Siti Najiha Md Asari[SUP] 1 [/SUP], Nazarudin Bin Safian[SUP] 2 3 [/SUP], Noor Khalili Mohd Ali[SUP] 4 [/SUP], Nadiatul Ima Zulkifli[SUP] 4 [/SUP]



Affiliations
Abstract

Identifying risk and protective factors associated with COVID-19 mortality among hospitalised patients is essential for improving clinical outcomes and guiding public health interventions. This study examined demographic, clinical, and public health factors associated with in-hospital mortality among COVID-19 patients in Malaysia. We conducted a cross-sectional analysis of epidemiological and clinical data from 1,795 confirmed COVID-19 patients admitted to a designated hospital in Negeri Sembilan between January and December 2021. Variables included age, sex, comorbidities, clinical symptoms, vaccination status, screening method (e.g., close contact, symptomatic, pre-procedure), and RT-PCR cycle threshold (CT) values. Univariable and multivariable logistic regression analyses were used to identify factors associated with mortality. A total of 224 patients (12.5%) died during hospitalisation. Mortality was significantly associated with age ≥ 71 years (aOR 14.02, 95% CI: 5.98-32.83), male sex (aOR 1.52, 95% CI: 1.11-2.07), and comorbidities including stroke (aOR 4.3, 95% CI: 1.3-14.06), chronic kidney disease (aOR 4.23, 95% CI: 1.99-9), and cancer (aOR 3.3, 95% CI: 1.1-10). Protective factors included complete COVID-19 vaccination (aOR 0.31, 95% CI: 0.11-0.98), close contact screening (aOR 0.45, 95% CI: 0.3-0.67), and symptomatic screening (aOR 0.59, 95% CI: 0.37-0.94). Complete vaccination and early case detection through close contact and symptomatic screening were associated with reduced mortality among hospitalised COVID-19 patients. These findings highlight the importance of strengthening vaccination programmes and early detection strategies to inform future pandemic preparedness and optimise hospital resource allocation.

Keywords: COVID-19; Malaysia; Mortality; Public health; Screening; Vaccination.

 
Back
Top Bottom